95 related articles for article (PubMed ID: 16887141)
1. Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity.
Wichlan DG; Roddam PL; Eldridge P; Handgretinger R; Riberdy JM
J Immunol Methods; 2006 Aug; 315(1-2):27-36. PubMed ID: 16887141
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
[TBL] [Abstract][Full Text] [Related]
3. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
[TBL] [Abstract][Full Text] [Related]
4. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.
Rensing-Ehl A; Gaus B; Bruckner-Tuderman L; Martin SF
Exp Dermatol; 2007 Jan; 16(1):13-21. PubMed ID: 17181632
[TBL] [Abstract][Full Text] [Related]
5. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
6. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
[TBL] [Abstract][Full Text] [Related]
7. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.
Banham AH
Trends Immunol; 2006 Dec; 27(12):541-4. PubMed ID: 17045841
[TBL] [Abstract][Full Text] [Related]
8. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.
Valencia X; Lipsky PE
Nat Clin Pract Rheumatol; 2007 Nov; 3(11):619-26. PubMed ID: 17968332
[TBL] [Abstract][Full Text] [Related]
10. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
Merlo A; Tagliabue E; Mènard S; Balsari A
Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
12. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
[TBL] [Abstract][Full Text] [Related]
13. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
14. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
15. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
16. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells.
Lopez M; Clarkson MR; Albin M; Sayegh MH; Najafian N
J Am Soc Nephrol; 2006 Oct; 17(10):2844-53. PubMed ID: 16914538
[TBL] [Abstract][Full Text] [Related]
18. Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells.
Dige A; Hvas CL; Kelsen J; Deleuran B; Dahlerup JF; Agnholt J
J Immunol Methods; 2010 Feb; 353(1-2):141-4. PubMed ID: 19958773
[TBL] [Abstract][Full Text] [Related]
19. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
20. Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.
Guillot-Delost M; Cheraï M; Hamel Y; Rosenzwajg M; Baillou C; Simonin G; Leclercq V; Mariotti-Ferrandiz ME; Six A; Bon-Durand V; Maury S; Salomon BL; Cohen JL; Klatzmann D; Lemoine FM
J Gene Med; 2008 Aug; 10(8):834-46. PubMed ID: 18615770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
